For the time being, then, the advent of generic biologicals will not significantly quash skyrocketing health care costs.

FORBES: Commentary

Eventually, the availability of generic biologicals will spur competition and reduce prices.

FORBES: Commentary

The rules would apply not only to traditional drugs but also to the more complicated so-called "biologicals, " which mimic proteins actually used by the body.

FORBES: Magazine Article

Thus, to anyone familiar with the scientific and regulatory aspects of biologicals, it is obvious that clinical trials--possibly large ones--will be required before the FDA approves generic versions.

FORBES: Commentary

Eventually, the availability of biosimilars will spur competition and reduce prices somewhat, and because of advances in technology, some of the follow-on products may even be superior to the original brand-name biologicals.

FORBES: Do You Think 'Biosimilars' Will Reduce Healthcare Expenditures? Think again.

Biologicals are made in living cells--usually bacteria, yeast or cultured mammalian cells that have been reprogrammed by the introduction of new genetic material to synthesize the drug, which is then highly purified.

FORBES: Commentary